May 15, 2012 -- BioCellChallenge has selected Bulldog Bio as its exclusive partner in the USA. Under the terms of this agreement, Bulldog Bio will stock, promote, sell and support BioCellChallenge’s entire line of molecular delivery reagents. These include novel chemistries for DNA and siRNA transfection experiments, and reagents for transporting proteins directly into cells.
“We’re very eager to introduce this comprehensive line of transfection tools to the North American research community.” Ella Fontaine, VP of Communications, further elaborates. “BCC’s reagents offer a completely new approach to introducing plasmid, siRNAs and proteins into the cytoplasm and nucleus of cells. We’re particularly excited about the encouraging results seen with primary and stem cells. Researchers will find these reagents effective and affordable.”
BioCellChallenge SAS is a privately held biotechnology company, founded in 2009. The company specializes in drug delivery systems and aims to provide very good tools to the scientific community so that scientists attain new heights in research.
Bulldog Bio Incorporated is a privately held company headquartered in Portsmouth, NH, that distributes tools to Life Science researchers. Please visit www.bulldog-bio.com for more information about the company and its products.
